Bristol-Myers&#39; experimental vein graft treatment fails
79583
Bristol-Myers Squibb Co. said an experimental treatment it is developing with Corgentech Inc. to treat vein grafts proved no better than a placebo in a late-stage clinical trial.
153875
BOSTON, Oct. 29 /PRNewswire/ -- Data to be presented at the 55th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) demonstrated that treatment with the Bristol-Myers Squibb
665303
A patient-compliance study shows that its only drug offers no better solution.
741757
TRENTON, N.J. - In a disappointing setback, a promising experimental AIDS vaccine failed to work in a large international test, leading the developer to halt the study.
535223
An experimental drug under development by Bristol-Myers Squibb is showing early promise in reversing the signs and symptoms of patients whose chronic myeloid leukemia failed to respond to Gleevec, which is considered the standard of treatment for the
646040
A heart treatment from Canadian   biotech firm Vasogen Inc., which failed a key clinical trial   hurdle in June, still helped more than 70 percent of patients,   researchers said on Sunday.
524078
Patients with a potentially fatal lung condition have spent hundreds of millions of dollars on a drug that was not approved for their disease but was promoted for that use.
452705
Maxim Pharmaceuticals Inc.  shares plunged nearly 60 percent on Monday after the company said its experimental liver cancer drug failed to show an improvement in patient survival rates during a clinical trial.
90262
Forest Laboratories Inc. (FRX.N: Quote, Profile, Research) on Tuesday said its experimental hypertension drug failed to meet all its goals in an effectiveness study, an outcome that will delay development and may lead to a new trial.
10766
The 13th patient to receive the world&#39;s first fully implantable artificial heart died Sunday night after an unexpected malfunction in the device made by Abiomed Inc.
758482
Biopure Corp. , the Cambridge company trying to develop an artificial substitute for human blood, was battered in the stock market yesterday after a federal advisory council recommended against its effort to test the product on more than 1,000 trauma patients.
550945
The catheter that triggered three safety recalls by Boston Scientific Corp. of its best-selling Taxus coronary stent after being linked to three deaths and 47 injuries had not been subjected to the rigors of a human clinical trial, FDA records show.
166901
Cellegy Pharmaceuticals Inc. shares lost nearly half their value in Monday trading after the Food and Drug Administration rejected the company&#39;s ointment for treating pain from chronic anal fissure.
509522
In an announcement that took doctors, patients and stock analysts by complete surprise, lung cancer drug Iressa failed to help patients live longer in a significant clinical trial.
177541
Forest Laboratories Inc. (FRX.N: Quote, Profile, Research) on Tuesday said its experimental treatment for Alzheimer&#39;s disease failed to prove effective in a large clinical trial, sending its shares lower in after-hours trading.
575659
Forest Laboratories Inc. (FRX) on Tuesday said its experimental hypertension drug failed to meet all its goals in an effectiveness study, an outcome that will delay development and may lead to a new trial.
445999
The Food and Drug Administration (FDA) learned yesterday from AstraZeneca that a large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival